Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Toremifene vs Tamoxifen in Advanced Breast Cancer
2026-08-14
This Cochrane review synthesized randomized evidence comparing toremifene with tamoxifen for advanced breast cancer and found no clear difference in tumor response, progression, survival, or selected adverse events. Its main practical contribution is a careful assessment of comparative endocrine therapy evidence, showing why an absence of demonstrated superiority should not automatically be interpreted as proof of equivalence.
-
Vorinostat: HDAC Inhibition in Cancer Research
2026-08-14
Vorinostat, also called suberoylanilide hydroxamic acid or SAHA, is a small-molecule histone deacetylase inhibitor used to study chromatin regulation and cancer-cell death. Its biochemical potency, cellular response range, solvent limitations, and lymphoma relevance make it useful for controlled epigenetic modulation in oncology research.
-
Novobiocin: From Target to Selectivity Window
2026-08-13
Novobiocin is an aminocoumarin antibiotic whose value extends beyond simple growth inhibition. This evidence-led guide shows how to interpret target engagement, host-cell selectivity, and endpoint choice when designing antiparasitic, antiviral, and antibacterial resistance studies.
-
Leucomycin (Kitasamycin): From Ribosome to Translation
2026-08-13
Leucomycin, also known as kitasamycin, offers translational researchers a practical bridge between ribosome biology, bacterial growth inhibition, and infection-model validation. This article examines its 23S rRNA-directed mechanism, resistance signals, evidence from experimentally infected pigs, and strategic use in antibacterial drug discovery and macrolide resistance characterization.
-
Ciclesonide Beyond Potency: A Translational Map
2026-08-12
Ciclesonide research is best understood through the relationship between prodrug activation, glucocorticoid receptor pharmacology, and assay context. This article also clarifies what the 2026 ERAD study does—and does not—show about translating corticosteroid chemistry into targeted protein degradation.
-
Deferiprone Workflows for Iron-Stress Assays
2026-08-12
Deferiprone enables controlled iron depletion for studying metabolism, proliferation, oxidative stress, and apoptosis across cell-based models. This guide translates recent enterocyte findings into practical workflows while addressing aqueous formulation, exposure timing, iron repletion, doxorubicin protection, and assay reproducibility.
-
EdU as a Translational Lens on Stem Cell Senescence
2026-08-11
A mechanistic and strategic guide to using EdU Imaging Kits (488) for resolving S-phase activity, senescence, and intervention response in disease-relevant stem-cell models, with preeclampsia-derived umbilical cord mesenchymal stem cells as the anchor example.
-
TRPV1 Modulation in Metastatic Breast Cancer Immunity
2026-08-11
This study shows that TRPV1 modulation produces sharply different cytokine responses in immune cells from healthy and metastatic breast cancer-bearing mice. Its central contribution is demonstrating that receptor activation may intensify, rather than suppress, tumor-associated inflammation, while AMG9810 can behave as an inverse agonist rather than a conventional antagonist.
-
Sex Differences in Angiotensin II Hypertension
2026-08-10
Xue, Pamidimukkala, and Hay used radiotelemetry in conscious mice to show that chronic angiotensin II produces substantially greater hypertension in males than females. Gonadectomy, baroreflex testing, and ganglionic blockade further linked this divergence to sex-dependent hormonal and sympathetic regulation rather than to baseline blood pressure alone.
-
ABT-737 BCL-2 Protein Inhibitor Workflows
2026-08-09
ABT-737 is a benchmark BH3 mimetic for dissecting mitochondrial apoptosis in cancer and senescence models. This guide connects practical dosing, orthogonal readouts, and reference-driven assay design to applications ranging from small-cell lung cancer research to senolytic screening.
-
2'3'-cGAMP: STING Signaling Research Guide
2026-08-08
2'3'-cGAMP (sodium salt) is an endogenous cGAS product and potent STING activator for studying type I interferon induction. This guide connects its molecular mechanism, product specifications, and evidence from a surgical brain injury model while separating validated findings from workflow recommendations.
-
N2703 in Adipose-Neural Arrhythmia Research
2026-08-07
Explore how 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) can support perturbation-based studies of adipose-neural signaling and cardiac arrhythmia. This article translates a multicellular reference model into practical assay-design and interpretation decisions without overstating the compound’s mechanism.
-
Rimonabant (SR141716): Translational Leverage in Cannabinoid
2026-08-07
Explore the mechanistic and translational dimensions of Rimonabant (SR141716) as a benchmark CB1 antagonist. This article provides advanced guidance for researchers dissecting endocannabinoid signaling in appetite, addiction, and inflammation, bridging foundational evidence with strategic, protocol-driven insights. See how recent sex-differentiated withdrawal studies, robust protocol parameters, and competitive positioning reframe the value of SR141716 for translational science.
-
Nanoparticle Properties Shape Ocular Drug Uptake in Corneal
2026-08-06
This study elucidates how nanoparticle size and surface chemistry govern the uptake of PLGA nanoparticles by human corneal epithelial cells, with implications for enhancing ocular drug delivery. The findings clarify dominant endocytic pathways, inform nanoparticle design, and highlight practical considerations for future translational research.
-
Gentamycin Sulfate in Advanced Bacterial Resistance Modeling
2026-08-06
Explore how Gentamycin Sulfate serves as a pivotal aminoglycoside antibiotic for high-fidelity bacterial resistance modeling and ribosome function analysis. This article uniquely examines its role in next-generation research workflows and integrates recent clinical microbiology findings for deeper scientific insights.